Skip to main content
Top
Published in: BMC Public Health 1/2022

Open Access 01-12-2022 | Human Papillomavirus | Research article

Predicting human papillomavirus vaccine uptake in men who have sex with men the influence of vaccine price and receiving an HPV diagnosis

Authors: Po-Yi Yao, Chung-Ying Lin, Nai-Ying Ko, Huachun Zou, Chia-Wen Lee, Carol Strong

Published in: BMC Public Health | Issue 1/2022

Login to get access

Abstract

Background

To understand how human papillomavirus (HPV) screening results, HPV-related knowledge and attitudes are related to vaccination intention in three cost ranges and the actual vaccination behavior in a community sample of men who have sex with men (MSM).

Methods

MSM aged 20 years of age or older were recruited between October 2015 and May 2016 from community health centers that provide HIV testing and consultation services in Southern Taiwan and on social media. MSM were seen at baseline and again at 6 months after baseline in a cohort study. The baseline study included 253 individuals; 182 of them returned for the 6th-month follow-up. At each visit, MSM were asked to receive HPV screening and filled out a questionnaire. Structural equation modeling was used to test whether attitudinal factors and HPV screening results from the baseline affect their self-reported actual vaccine uptake at the in 6th-month follow-up.

Results

Our research included 171 participants from the cohort because they had full information of the study variables (mean ± SD age = 29.21 ± 6.18). Our model showed good model fit using indices such as the comparative fit index (value = 0.998) and root mean square error of approximation (value = 0.013). HPV knowledge can predict those who have intention to take up HPV vaccine no matter what the price (p = .02), and then predict vaccine uptake at the follow-up (p < .001). A positive HPV screening result can predict vaccine uptake at the follow-up (p = .004).

Conclusion

Our findings highlight the impact of vaccine price and HPV screening results on the intention and uptake of HPV vaccine. It is important to raise awareness of HPV in male populations. Clinicians and health educators should establish a safe and private environment for male patients for inquiring about HPV vaccine and HPV-related cancers.
Appendix
Available only for authorised users
Literature
2.
go back to reference Bloem P, Ogbuanu I. Vaccination to prevent human papillomavirus infections: From promise to practice. PLoS Med. 2017;14(6):e1002325.CrossRef Bloem P, Ogbuanu I. Vaccination to prevent human papillomavirus infections: From promise to practice. PLoS Med. 2017;14(6):e1002325.CrossRef
17.
go back to reference Hoyle, R. H., & Panter, A. T. (1995 ). Writing about structural equation models. In: R. H. Hoyle (Ed),Structural Equation Modeling, Concepts, Issues, and Applications. Thousand Oaks, CA: Sage Hoyle, R. H., & Panter, A. T. (1995 ). Writing about structural equation models. In: R. H. Hoyle (Ed),Structural Equation Modeling, Concepts, Issues, and Applications. Thousand Oaks, CA: Sage
18.
go back to reference Health Promotion Administration, Ministry of Health and Welfare. HPV QA. Taiwan; 2020. Health Promotion Administration, Ministry of Health and Welfare. HPV QA. Taiwan; 2020.
29.
go back to reference Oliver, S. E., Hoots, B. E., Paz-Bailey, G., Markowitz, L. E., Meites, E., & Group., N. S. Increasing human papillomavirus vaccine coverage among men who have sex with men—National HIV Behavioral Surveillance, United States, 2014. J Acquir Immune Defic Syndr. 2017;75(Supplement 3):S370-374. Oliver, S. E., Hoots, B. E., Paz-Bailey, G., Markowitz, L. E., Meites, E., & Group., N. S. Increasing human papillomavirus vaccine coverage among men who have sex with men—National HIV Behavioral Surveillance, United States, 2014. J Acquir Immune Defic Syndr. 2017;75(Supplement 3):S370-374.
31.
go back to reference Petrosky E, Bocchini JA Jr, Hariri S, Chesson H, Curtis CR, Saraiya M, Markowitz LE. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. Morb Mortal Wkly Rep. 2015;64(11):300. Petrosky E, Bocchini JA Jr, Hariri S, Chesson H, Curtis CR, Saraiya M, Markowitz LE. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. Morb Mortal Wkly Rep. 2015;64(11):300.
35.
go back to reference Rosenthala SL, Weissb TW, Zimetc GD, Mab L, Goodd MB, Vichninb MD. Predictors of HPV vaccine uptake among women aged 19–26: Importance of a physician’s recommendation. Vaccine. 2011;29(5):890–5.CrossRef Rosenthala SL, Weissb TW, Zimetc GD, Mab L, Goodd MB, Vichninb MD. Predictors of HPV vaccine uptake among women aged 19–26: Importance of a physician’s recommendation. Vaccine. 2011;29(5):890–5.CrossRef
45.
go back to reference Zhang L, Regan DG, Ong JJ, Gambhir M, Chow EP, Zou H, Fairley CK. Targeted human papillomavirus vaccination for young men who have sex with men in Australia yields significant population benefits and is cost-effective. Vaccine. 2017;35(37):4923–9.CrossRef Zhang L, Regan DG, Ong JJ, Gambhir M, Chow EP, Zou H, Fairley CK. Targeted human papillomavirus vaccination for young men who have sex with men in Australia yields significant population benefits and is cost-effective. Vaccine. 2017;35(37):4923–9.CrossRef
Metadata
Title
Predicting human papillomavirus vaccine uptake in men who have sex with men the influence of vaccine price and receiving an HPV diagnosis
Authors
Po-Yi Yao
Chung-Ying Lin
Nai-Ying Ko
Huachun Zou
Chia-Wen Lee
Carol Strong
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2022
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-021-12396-y

Other articles of this Issue 1/2022

BMC Public Health 1/2022 Go to the issue